Skip to main content

Table 2 Patient characteristics over the 10 year study period with and without ECMO patients

From: Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation

Characteristic, n (%) All patients including ECMO All patients excluding ECMO
Patients (n) 311 273
Age (n)
 0 to 1 yr. 73 (23%) 56 (21%)
 1 to 3 yr 37 (12%) 34 (12%)
 3 to 5 yr 23 (7%) 23 (8%)
 5 to 10 yr 41 (13%) 38 (14%)
 10 to 15 yr 63 (20%) 57 (21%)
 15 to 21 yr 64 (21%) 55 (20%)
  > 21 yr 10 (3%) 10 (4%)
  Mean (SD) 8.2 (7.0) 8.4 (7.0)
Weight (n)
 0 to 10 kg 82 (26%) 64 (23%)
 10 to 20 kg 71 (23%) 68 (25%)
 20 to 50 kg 80 (26%) 68 (25%)
  > 50 kg 78 (25%) 73 (27%)
  Mean (SD) 33 (28.1) 33.5 (27.2)
Pre-existing end-stage renal disease 13 (4%) 13 (5%)
Sepsis on admission 36 (13%) 34 (14%)
Immunocompromised
 Solid organ transplant 67 (22%) 58 (21%)
 BMT 33 (11%) 31 (11%)
 Other immunocompromised 54 (17%) 51 (19%)
 Not immunocompromised 156 (50%) 132 (49%)
% Fluid overload at CRRT Start a 15 (7, 26) 15 (8, 26)
Hospital Unit of CRRT Start
 Pediatric Intensive Care Unit 257 (83%) 241 (89%)
 Neonatal Intensive Care Unit 22 (7%) 14 (5%)
 Cardiovascular Intensive Care Unit 29 (9%) 15 (6%)
 Bone Marrow Transplant Unit 1 (0.3%) 1 (0.4%)
ICU survival 154 (50%) 145 (53%)
28 day survival 176 (57%) 165 (60%)
60 day survival 156 (50%) 146 (53%)
Survival to discharge 139 (45%) 131 (48%)
Outpatient Renal Follow-up b 62 (45%) 58 (44%)
  1. aMedian with (interquartile range)
  2. bPatients who received CRRT for non-renal indications were excluded from this cohort (inborn errors of metabolism, ingestion)